CUSIP: 00484MAA4
Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Debt / NOTE 1.750% 6/1
-
Market price (% of par)
-
55.01%
-
Total 13F principal
-
$58,705,000
-
Principal change
-
+$500,000
-
Total reported market value
-
$33,077,000
-
Number of holders
-
11
-
Value change
-
+$275,043
-
Number of buys
-
1
Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 as of Q4 2020
As of 31 Dec 2020,
ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 was held by
11 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$58,705,000
in principal (par value) of the bond.
The largest 10 bondholders included
WELLS FARGO & COMPANY/MN, Bruce & Co., Inc., GOLDMAN SACHS GROUP INC, UBS OCONNOR LLC, CREDIT SUISSE AG/, AMERIPRISE FINANCIAL INC, FMR LLC, PFM Health Sciences, LP, MORGAN STANLEY, and CAPSTONE INVESTMENT ADVISORS, LLC.
This page lists
11
institutional bondholders reporting positions
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.